TRPC3 induces intervertebral disc degeneration by mediating the Ca2+/NF-κB pathway to inhibit autophagy

Advances in Clinical and Experimental Medicine · Published 2026-05-05 · DOI 10.17219/acem/207572

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.17219/acem/207572

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Gastrointestinal manifestations of systemic lupus erythematosus (SLE): A comprehensive literature review · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Platelet-rich plasma plus hyaluronic acid vs platelet-rich plasma intra-articular injections for knee osteoarthritis: A systematic review and meta-analysis · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Preoperative psychological nursing reduces stress and postoperative complications in patients undergoing ERCP: A prospective cohort study · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Counteracting obesity discrimination and stigma: A scoping review · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Impact of primary tumor SUVmax on PET accuracy in mediastinal lymph node staging of non-small cell lung cancer (NSCLC) · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Global, regional, and national burden of gastroesophageal reflux disease (GERD), 1990–2021, with projections to 2050 · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Antibiotic resistance and molecular characteristics of OXA-48-producing Klebsiella pneumoniae isolates from northeastern Poland · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Nanog promotes proliferation, migration, and invasion of gastric cancer cells via regulation of the KDM5B/H3K4me3 epigenetic axis · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Balancing osteogenesis and adipogenesis in osteogenesis imperfecta: PLIN2 and E2F2 as key targets for mesenchymal stem cell therapy · Advances in Clinical and Experimental Medicine · 2026 · Same journal
• Mendelian randomization analysis of metabolic blood biomarkers and gastrointestinal cancer risk · Advances in Clinical and Experimental Medicine · 2026 · Same journal